Roy T Daniel
Overview
Explore the profile of Roy T Daniel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cossu G, Ramsay D, Daniel R, El Cadhi A, Kerherve L, Morlaix E, et al.
Cancers (Basel)
. 2024 Oct;
16(20).
PMID: 39456573
: The recent discovery of BRAF mutation in papillary craniopharyngiomas opened new avenues for targeted therapies to control tumour growth, decreasing the need for invasive treatments and relative complications. The...
2.
Giammattei L, Fava A, Starnoni D, Cossu G, Daniel R, Messerer M
J Clin Neurosci
. 2024 Oct;
129:110866.
PMID: 39423488
Background: Endoscopic endonasal posterior clinoidectomy represents an important maneuver to improve access and visualization of the retrosellar and upper clivus area [1]. Three different techniques have been described in order...
3.
Suero Molina E, Bruneau M, Reuter G, Shahein M, Cavallo L, Daniel R, et al.
Brain Spine
. 2024 Sep;
4:103328.
PMID: 39309550
Introduction: Intraoperative fluorescence guidance is a well-established surgical adjunct in high-grade glioma surgery. In contrast, the clinical use of such dyes and technology has been scarcely reported in skull base...
4.
Watson S, Zomer A, Fournier N, Lourenco J, Quadroni M, Chryplewicz A, et al.
Cancer Cell
. 2024 Sep;
42(9):1507-1527.e11.
PMID: 39255775
Glioblastoma recurrence is currently inevitable despite extensive standard-of-care treatment. In preclinical studies, an alternative strategy of targeting tumor-associated macrophages and microglia through CSF-1R inhibition was previously found to regress established...
5.
Giammattei L, Peters D, Cadas H, Fava A, Schranz S, George M, et al.
Oper Neurosurg (Hagerstown)
. 2024 Jun;
28(1):96-106.
PMID: 38917345
Background And Objectives: The combined petrosal intertentorial approach (CPIA) has been proposed as an alternative to standard combined petrosal approach (SCPA). CPIA has been designed to maintain integrity of the...
6.
Starnoni D, Daniel R, Messerer M
Acta Neurochir (Wien)
. 2024 Jun;
166(1):273.
PMID: 38890156
Background: Invasion of the CS is one of the limiting factors for total resection for PitNet tumors with cure rates less than 30%. Extended approaches may be considered in selective...
7.
Cossu G, Vandenbulcke A, Zaccarini S, Gaudet J, Hottinger A, Rimorini N, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730736
Background: Awake craniotomy (AC) is recommended for the resection of tumors in eloquent areas. It is traditionally performed under monitored anesthesia care (MAC), which relies on hypnotics and opioids. Hypnosis-assisted...
8.
Vandenbulcke A, Messerer M, Garvayo Navarro M, Peters D, Starnoni D, Giammattei L, et al.
Acta Neurochir (Wien)
. 2024 Mar;
166(1):133.
PMID: 38472426
Purpose: Intrathecal vasoactive drugs have been proposed in patients with aneurysmal subarachnoid hemorrhage (aSAH) to manage cerebral vasospasm (CV). We analyzed the efficacy of intracisternal nicardipine compared to intraventricular administration...
9.
Peters D, Tuleasca C, Giammattei L, Starnoni D, Daniel R
J Neurosurg
. 2024 Feb;
140(6):1818-1820.
PMID: 38394659
No abstract available.
10.
Gonzalez-Lopez P, Kuptsov A, Gomez-Revuelta C, Fernandez-Villa J, Abarca-Olivas J, Daniel R, et al.
J Pers Med
. 2024 Feb;
14(2).
PMID: 38392620
Our study explores the integration of three-dimensional (3D) virtual reality (VR) and 3D printing in neurosurgical preoperative planning. Traditionally, surgeons relied on two-dimensional (2D) imaging for complex neuroanatomy analyses, requiring...